Podcasts about hiv epidemic a plan

HIV/AIDS experts are cautiously watching as President Trump and his administration near inauguration day. On one hand, they remember how President Trump announced in 2019 his initiative called Ending the HIV Epidemic: A Plan for America. It included Ready, Set, PrEP, a U.S. Department of Health and Human Services initiative that provides free access to the HIV prevention medication PrEP for thousands of qualifying individuals. But there are worries “about the next four years because we're hearing about a potential decrease in funding,” that will be detrimental to programs, according to Dr. Marwan Haddad, Medical Director of the Center for Key Populations, Community Health Center, Inc., and a former chair of the HIV Medicine Association. Vincent Guilamo-Ramos, Ph.D., MPH, Executive Director, Institute for Policy Solutions at the Johns Hopkins School of Nursing, highlighted these issues as communities recognized World AIDS Day on Dec. 1. For instance, the CDC reports new HIV infections fell by 19% from 2018 to 2022 but there's been a 12% increase in infections among Latino people. Our guests join hosts Mark Masselli and Margaret Flinter to discuss progress and the hurdles that still exist in the fight to end AIDS. Learn more about your ad choices. Visit podcastchoices.com/adchoices

HIV/AIDS experts are cautiously watching as President Trump and his administration near inauguration day. On one hand, they remember how President Trump announced in 2019 his initiative called Ending the HIV Epidemic: A Plan for America. It included Ready, Set, PrEP, a U.S. Department of Health and Human Services initiative that provides free access to the HIV prevention medication PrEP for thousands of qualifying individuals.But there are worries “about the next four years because we're hearing about a potential decrease in funding,” that will be detrimental to programs, according to Dr. Marwan Haddad, Medical Director of the Center for Key Populations, Community Health Center, Inc., and a former chair of the HIV Medicine Association. Vincent Guilamo-Ramos, Ph.D., MPH, Executive Director, Institute for Policy Solutions at the Johns Hopkins School of Nursing, highlighted these issues as communities recognized World AIDS Day on Dec. 1. For instance, the CDC reports new HIV infections fell by 19% from 2018 to 2022 but there's been a 12% increase in infections among Latino people.Our guests join hosts Mark Masselli and Margaret Flinter to discuss progress and the hurdles that still exist in the fight to end AIDS. Learn more about your ad choices. Visit podcastchoices.com/adchoicesSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Originally broadcast December 5, 2024 HIV/AIDS experts are cautiously watching as President Trump and his administration near inauguration day. On one hand, they remember how President Trump announced in 2019 his initiative called Ending the HIV Epidemic: A Plan for America. It included Ready, Set, PrEP, a U.S. Department of Health and Human Services initiative that provides free access to the HIV prevention medication PrEP for thousands of qualifying individuals. But there are worries “about the next four years because... Read More Read More The post Pres. Trump's HIV/AIDS Record: A Look Back & Ahead appeared first on Healthy Communities Online.

HIV/AIDS has killed about 700,000 people in the U.S. since it first emerged more than 40 years ago. But deaths have dropped dramatically since the mid-‘90s as new treatments have beome available. The U.S. Department of Health and Human Services in 2019 launched the Ending the HIV Epidemic Initiative that aims to eliminate the disease in this country. On this podcast, we talk with Dr. Jonathan Mermin, director of the National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention at the Centers for Disease Control and Prevention. He discusses the range of treatments available to fight HIV/AIDS, strategies to prevent spread of the disease and the role state policymakers can play in helping eradicate the disease. Our other guest if Charlie Severance-Medaris, a policy expert at NCSL. Charlie explains the steps states are taking to help people to get access to critical medications, changes in laws that have criminalized some behaviors for people with HIV/AIDS, and other efforts at the state level to end the epidemic.       Resources Ending the HIV Epidemic: A Plan for America, CDC Ending the HIV Epidemic: Jurisdictional Plans, NASTAD HIV and STD Criminalization Laws, CDC National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention NCSL’s Injury Prevention Database NCSL’s Substance Use Disorder Treatment Database OAS Episode 121 Transcription Preventing Infectious Diseases Caused by Injecting Drugs Syringe Service Programs, CDC

We’re in the midst of a global pandemic and, of course, everyone’s attention is focused on COVID-19. Other podcasts have excellent coverage of this situation. In this episode, we’ll be discussing other important infections that continue to affect our communities: HIV, hepatitis C, and syphilis. Over the past year, the UC Davis ED implemented a massive screening effort to identify patients who have become infected. Dr. Larissa May explains how the screening works and some of the surprising trends we’ve seen. Infection rates were higher than expected and many patients had no idea they were infected! One patient tells us how screening positive for HIV, and being connected to care, changed his life.  This topic, as with so many issues we cover, brings up the broader question: what is the role of the emergency department in the healthcare system? We will explore this further in an upcoming episode and we would love to hear from YOU.  What do YOU see as the role of the emergency department in the broader health system? Send us your answer via on social media, @empulsepodcast, or through our website, ucdavisem.com. And please pass the word along to your friends and colleagues! ***Please rate us and leave us a review on iTunes! It helps us reach more people.*** Hosts: Dr. Julia Magaña, Assistant Professor of Pediatric Emergency Medicine at UC Davis Dr. Sarah Medeiros, Assistant Professor of Emergency Medicine at UC Davis Guest: Dr. Larissa May, Professor of Emergency Medicine with a Masters in Emerging Infectious Diseases, and Director of Emergency Department Antibiotic Stewardship at UC Davis. Resources: ACEP Policy Statement on HIV testing and screening in the ED Centers for Disease Control and Prevention (CDC) resources: Ending the HIV Epidemic: A Plan for America. HIV Nexus Clinician Resources Haukoos JS, Lyons MS, Rothman RE. The Evolving Landscape of HIV Screening in the Emergency Department. Ann Emerg Med. 2018 Jul;72(1):54-56. doi: 10.1016/j.annemergmed.2018.01.041. Epub 2018 Feb 17. PubMed PMID: 29459057; Leblanc J, Hejblum G, Costagliola D, Durand-Zaleski I, Lert F, de Truchis P, Verbeke G, Rousseau A, Piquet H, Simon F, Pateron D, Simon T, Crémieux AC; DICI-VIH (Dépistage Infirmier CIblé du VIH) Group. Targeted HIV Screening in Eight Emergency Departments: The DICI-VIH Cluster-Randomized Two-Period Crossover Trial. Ann Emerg Med. 2018 Jul;72(1):41-53.e9. doi: 10.1016/j.annemergmed.2017.09.011. Epub 2017 Oct 31. *** Thank you to the UC Davis Department of Emergency Medicine for supporting this podcast and to Orlando Magaña at OM Audio Productions for audio production services.

A set of commissioned papers in the January issue discusses the public health initiative entitled "Ending the HIV Epidemic: A Plan for America." Here I interview Admiral Brett Giroir, the Assistant Secretary of Health, leader of the Plan, and ask questions regarding stakeholders, hard-to-reach populations, stigma against LGBTQ people and people who inject drugs, the obstacles of low insurance coverage and lack of Medicaid expansion.

Dr. Robert Redfield is the director of the Centers for Disease Control and Prevention (CDC) and administrator of the Agency for Toxic Substances and Disease Registry. Prior to becoming CDC’s Director, Dr. Redfield had a long and distinguished career in public health, including researching and contributing to the early scientific understanding of HIV, serving as the chief of infectious diseases and vice chair of medicine at the University of Maryland School of Medicine, and serving on the president’s advisory council on HIV/AIDS from 2005 to 2009. In this episode, Dr. Redfield shares his thoughts on eliminating HIV in the United States by 2030, why opioid disorder is the public health crisis of our time, and what it’s like to work with a team that puts science and data into action to improve the human condition. For more information and full episode transcription go to Contagious Conversations (www.cdcfoundation.org/conversations).   Key Takeaways: [1:21] Dr. Redfield’s career path. [3:11] Dr. Redfield in his early years working with HIV. [6:45] Starting at CDC. [7:19] Three priority areas at CDC. [10:21] A plan to eliminate HIV in the USA by 2030. [11:10] Prevention strategies are critical to public health. [14:09] Progress made in opioid addiction. [15:05] Drug use disorder as a medical condition and not a moral failing. [15:51] The challenge with drug use disorder is confronting stigma. [16:13] Where we are doing to address opioid addiction. [19:18] Using data to address public health challenges. [22:47] Dr. Redfield’s ambitious goals during his term at CDC. [23:25] The most challenging part of being director of CDC. [24:28] The most rewarding part of being CDC’s director. [26:16] The biggest misconception about CDC’s work. [28:26] The impact of CDC’s work globally. [30:19] The importance of global health security. [32:33] Public-private partnerships accomplish key goals. [35:35] What Dr. Redfield has learned over the past year about CDC’s team. [36:34] CDC’s team and being on the frontlines of public service.   Mentioned in This Episode: CDC Foundation Ending the HIV Epidemic: A Plan for America PEPFAR Answer this episode’s question: How has the work of CDC impacted your life? Email your answer to info@cdcfoundation.org and win some CDC Foundation merchandise.

In the early days of the HIV/AIDS crisis in the 1980’s, a diagnosis of HIV was a death sentence. Now, infection with the human immunodeficiency virus is a chronic, treatable condition. Even more promising, medicines have been developed which curb the acquisition of HIV entirely.Today on Midday, a conversation about the feasibility of ridding the world of AIDS in the next decade. What strategies and treatments are working, and what still needs to be accomplished? Earlier this summer, the Centers for Disease Control and Prevention released a report titled “Ending the HIV Epidemic: A Plan for America.” The plan focuses on a four pronged approach to ending the epidemic. Diagnose, Treat, Prevent and Respond. Will it work?Tom talks with a panel of local physicians and advocates involved in Baltimore's HIV prevention and treatment efforts...Dr. Sebastian Ruhs is the Director of the Infectious Diseases Center of Excellence at Chase Brexton Health Care.Dr. Errol Fields is an Assistant Professor of Pediatrics at the the Johns Hopkins School of Medicine. He holds a joint appointment in the Bloomberg School of Public Health.Dr. Kathleen Page is an Associate Professor in the Division of Infectious Diseases at Johns Hopkins University School of Medicine and the Co-Director of Centro Sol.Mimi Demissew is the Executive Director at the Pride Center of Maryland.And, Dr. Adena Greenbaum is the Assitant Commissioner of the Bureau of Clinical Services for the Baltimore City Health DepartmentFor more information on the programs discussed on today's show visit:www.solovive.orgwww.uequalsumaryland.orgwww.prepmaryland.orgwww.baltimoreinconversation.comThis conversation was live-streamed on WYPR's Facebook page. You can watch the video here.

Listen as the CSIS Global Health Policy Center discusses the “Ending the HIV Epidemic: A Plan for the United States” campaign, which will aim to end the HIV epidemic in the United States by 2030. This discussion features Dr. Anthony S. Fauci, Director of the National Institute of Allergy and Infectious Diseases, at the National Institutes of Health and Dr. Robert R. Redfield, Director of the U.S. Centers for Disease Control and Prevention. Dr. Fauci and Dr. Redfield will describe how this strategy first came to fruition and share the details of this 10-year plan, including expectations around financing and coordination, outreach to marginalized communities, and addressing a variety of implementation challenges.

On February 5, 2019, President Trump announced in his State of the Union address the launch of an ambitious campaign, “Ending the HIV Epidemic: A Plan for the United States”, which will aim to end the HIV epidemic in the United States by 2030.  Plans are actively in development to accelerate diagnosis, treatment, and prevention—including a dramatic increase in the use of pre-exposure prophylaxis (PreP) —in 48 counties, rural communities in 7 states that have a disproportionate occurrence of HIV, Washington, D.C., and San Juan, Puerto Rico. Together, these areas account for more than half of all new HIV diagnoses in 2016 and 2017.  A budget request for year 1 in the amount of $291 million has gone forward to Congress, and the operational kick-off for programs is set for early 2020. Please join the CSIS Global Health Policy Center for a discussion with the two main architects of this strategy—Dr. Anthony S. Fauci, Director of the National Institute of Allergy and Infectious Diseases, at the National Institutes of Health and Dr. Robert R. Redfield, Director of the U.S. Centers for Disease Control and Prevention.  Dr. Fauci and Dr. Redfield will describe how this strategy first came to fruition and share the details of this 10-year plan, including expectations around financing and coordination, outreach to marginalized communities, and addressing a variety of implementation challenges.    This event will feature opening remarks by Sara M. Allinder, CSIS Global Health Policy Center Executive Director and Senior Fellow, and presentations from Dr. Fauci and Dr. Redfield, followed by a conversation moderated by J. Stephen Morrison, Senior Vice President and Director of the CSIS Global Health Policy Center.This event is made possible by the general support to CSIS.

Overview: In March 2018, Robert R. Redfield became the 18th director of CDC, bringing to the role more than 30 years of experience as a public health leader engaged in the clinical research and care of viral infections and infectious diseases, especially HIV. Since then, HHS and President Trump have announced an ambitious plan to end HIV in America, a cause which Redfield considers a prominent part of his life’s work. But public health challenges remain, including the opioid epidemic and anti-vaccine movement. In this wide-ranging conversation, Redfield shares insights into how his own personal experiences have shaped his priorities as CDC director, the importance of improved communication around vaccine education, CDC’s strategy to end HIV transmission, and how the agency plans to support states and territories as they address the opioid epidemic and other public health challenges.    Guest: Robert R. Redfield, MD, Director, Centers for Disease Control and Prevention and Administrator of the Agency for Toxic Substances and Disease Registry    Resources: CDC Strategic Framework Ending the HIV Epidemic: A Plan for America

In this podcast, Dr Anthony Fauci from the National Institutes of Health (NIH) discusses his session at the Conference on Retroviruses and Opportunistic Infections (CROI) 2019: "Ending the HIV Epidemic: A Plan for the United States." For more CROI 2019 coverage, visit https://www.consultant360.com/specialty/infectious-diseases/conference-retroviruses-and-opportunistic-infections-2019.